Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 148

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome—An Update

Takakura, Will, Pimentel, Mark·2020·Frontiers in Psychiatry
DOI 10.3389/fpsyt.2020.00664
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2020.00664

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 75

  1. Lacy, 2016, Bowel Disorders, Gastroenterology, 150, 10.1053/j.gastro.2016.02.031 · DOI · Paper page
  2. Rezaie, 2017, Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus, Am J Gastroenterol, 112, 10.1038/ajg.2017.46 · DOI · Paper page
  3. Pimentel, 2020, ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth, Am J Gastroenterol, 115, 10.14309/ajg.0000000000000501 · DOI · Paper page
  4. Levitt, 1971, Volume and composition of human intestinal gas determined by means of an intestinal washout technic, N Engl J Med, 284, 10.1056/NEJM197106242842502 · DOI
  5. Bond, 1971, Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria, J Exp Med, 133, 10.1084/jem.133.3.572 · DOI · Paper page
  6. Christl, 1992, Production, metabolism, and excretion of hydrogen in the large intestine, Gastroenterology, 102, 10.1016/0016-5085(92)90765-Q · DOI
  7. Hwang, 2010, Evaluating breath methane as a diagnostic test for constipation-predominant IBS, Dig Dis Sci, 55, 398, 10.1007/s10620-009-0778-4 · DOI
  8. Ghoshal, 2016, Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production, Gut Liver, 10, 10.5009/gnl15588 · DOI
  9. Takakura, 2019, Patients with Appendectomy Have Significantly Less Methane in Their Exhaled Breath: is the Appendix a Vestigial Organ Or an Important Reservoir for Methanogens, Gastroenterology, 156, S, 10.1016/S0016-5085(19)39870-1 · DOI
  10. Weaver, 1986, Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis, Gut, 27, 698, 10.1136/gut.27.6.698 · DOI
  11. Eckburg, 2005, Diversity of the human intestinal microbial flora, Science, 308, 10.1126/science.1110591 · DOI · Paper page
  12. Shah, 2020, Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies, Am J Gastroenterol, 115, 190, 10.14309/ajg.0000000000000504 · DOI
  13. Wu, 2019, Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance, Scand J Gastroenterol, 54, 1, 10.1080/00365521.2019.1694067 · DOI
  14. Parodi, 2009, Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution, J Clin Gastroenterol, 43, 10.1097/MCG.0b013e3181a099a5 · DOI
  15. Park, 2010, [Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome], Korean J Gastroenterol, 56, 10.4166/kjg.2010.56.4.242 · DOI
  16. Sachdeva, 2011, Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors, J Gastroenterol Hepatol, 10.1111/j.1440-1746.2011.06654.x · DOI
  17. Bertelè, 2012, P.07.16 Bacterial Overgrowth In Irritable Bowel Syndrome: A Cohort Study, Digest Liver Dis, 44, S132, 10.1016/S1590-8658(12)60365-X · DOI
  18. Philip, 2013, SI-11 Prevalence of small intestinal bacterial overgrowth in patients with irritable bowel syndrome using lactulose hydrogen breath test, Indian J Gastroenterol, 32, 1, 10.1007/s12664-013-0417-z · DOI
  19. Qing, 2013, Relationship betweeen the irritable bowel syndrome and small intestinal bacterial, J Gastroenterol Hepatol, 28, 23
  20. Li, 2014, Measurement of methane and hydrogen on lactulose breath test detects small intestinal bacterial overgrowth in patients with irritable bowel syndrome, Neurogastroenterol Motil, 26, 11
  21. Moraru, 2014, Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania, Rom J Intern Med, 52
  22. Lombardo, 2010, Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, 8, 10.1016/j.cgh.2009.12.022 · DOI · Paper page
  23. Evans, 2012, PWE-050 Does small intestine bacterial overgrowth cause neurodysmotility in IBS and coeliac disease, Gut, 61, 10.1136/gutjnl-2012-302514d.50 · DOI
  24. Abbasi, 2015, Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iran, Middle East J Dig Dis, 7, 36
  25. Chu, 2016, Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines, Gastroenterol Res Pract, 2016, 3230859, 10.1155/2016/3230859 · DOI
  26. Pimentel, 2003, Methane production during lactulose breath test is associated with gastrointestinal disease presentation, Dig Dis Sci, 48, 86, 10.1023/A:1021738515885 · DOI
  27. Chatterjee, 2007, The degree of breath methane production in IBS correlates with the severity of constipation, Am J Gastroenterol, 102, 10.1111/j.1572-0241.2007.01072.x · DOI
  28. Suri, 2018, Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit, Med (Baltimore), 97, e10554, 10.1097/MD.0000000000010554 · DOI
  29. Miller, 1985, Methanosphaera stadtmaniae gen. nov., sp. nov.: a species that forms methane by reducing methanol with hydrogen, Arch Microbiol, 141, 10.1007/BF00423270 · DOI · Paper page
  30. Miller, 1982, Isolation of Methanobrevibacter smithii from human feces, Appl Environ Microbiol, 43, 10.1128/AEM.43.1.227-232.1982 · DOI
  31. Kim, 2012, Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath, Dig Dis Sci, 57, 10.1007/s10620-012-2197-1 · DOI
  32. Florin, 1995, Inhibition of methanogenesis by human bile, Gut, 37, 10.1136/gut.37.3.418 · DOI
  33. Leite, 2020, The microbiome in small intestinal bacterial overgrowth: the REIMAGINE study, PloS One, 10.1371/journal.pone.0234906 · DOI
  34. Ghoshal, 2014, Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture, Eur J Gastroenterol Hepatol, 26, 10.1097/MEG.0000000000000122 · DOI · Paper page
  35. Pyleris, 2012, The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome, Dig Dis Sci, 57, 10.1007/s10620-012-2033-7 · DOI
  36. Rezaie, 2017, Autoimmunity as a Potential Cause of Post-Infectious Gut Dysmotility: A Longitudinal Observation, Am J Gastroenterol, 112, 10.1038/ajg.2017.8 · DOI
  37. Cohen, 2013, Increased risk for irritable bowel syndrome after acute diverticulitis, Clin Gastroenterol Hepatol, 11, 10.1016/j.cgh.2013.03.007 · DOI
  38. Shah, 2012, Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome, J Neurogastroenterol Motil, 18, 10.5056/jnm.2012.18.2.200 · DOI
  39. Zuckerman, 1993, Intestinal permeability to [51Cr]EDTA in infectious diarrhea, Dig Dis Sci, 38, 10.1007/BF01303174 · DOI
  40. Dunlop, 2006, Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes, Am J Gastroenterol, 101, 10.1111/j.1572-0241.2006.00672.x · DOI · Paper page
  41. Zhang, 2010, Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo, Microb Pathog, 48, 28, 10.1016/j.micpath.2009.10.002 · DOI
  42. Hullar, 2014, Diet, the gut microbiome, and epigenetics, Cancer J, 20, 10.1097/PPO.0000000000000053 · DOI
  43. Pozuelo, 2015, Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome, Sci Rep, 5, 12693, 10.1038/srep12693 · DOI
  44. Moloney, 2015, Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition, Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc, 27, 10.1111/nmo.12675 · DOI
  45. Rapin, 2010, Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine, Clinics (Sao Paulo), 65, 10.1590/S1807-59322010000600012 · DOI
  46. Hulsewe, 2004, Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability, Clin Nutr, 23, 10.1016/j.clnu.2004.04.002 · DOI
  47. Bercik, 2004, Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction, Gastroenterology, 127, 10.1053/j.gastro.2004.04.006 · DOI
  48. Chen, 2017, Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model, Scand J Gastroenterol, 52, 10.1080/00365521.2017.1342141 · DOI
  49. Pimentel, 2008, A new rat model links two contemporary theories in irritable bowel syndrome, Dig Dis Sci, 53, 10.1007/s10620-007-9977-z · DOI
  50. Pokkunuri, 2012, Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome, J Neurogastroenterol Motil, 18, 10.5056/jnm.2012.18.4.434 · DOI
  51. Pimentel, 2015, Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model, Dig Dis Sci, 60, 10.1007/s10620-014-3435-5 · DOI
  52. Bays, 2017, Vinculin in cell-cell and cell-matrix adhesions, Cell Mol Life Sci, 74, 2999, 10.1007/s00018-017-2511-3 · DOI · Paper page
  53. Schmulson, 2016, Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico, Rev Gastroenterol Mex, 81, 10.1016/j.rgmxen.2016.07.002 · DOI
  54. Rezaie, 2017, Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome, Dig Dis Sci, 62, 10.1007/s10620-017-4585-z · DOI
  55. Morales, 2019, Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels, Dig Dis Sci, 64, 10.1007/s10620-019-05684-6 · DOI
  56. Pike, 2015, Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome, J Travel Med, 22, 10.1111/jtm.12218 · DOI
  57. Talley, 2019, Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome, Clin Transl Gastroenterol, 10, e00064, 10.14309/ctg.0000000000000064 · DOI
  58. Gasbarrini, 2007, Small intestinal bacterial overgrowth: diagnosis and treatment, Dig Dis, 25, 10.1159/000103892 · DOI
  59. Bala, 2006, Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy, Magn Reson Med, 56, 10.1002/mrm.21041 · DOI
  60. Shah, 2013, Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth, Aliment Pharmacol Ther, 38, 10.1111/apt.12479 · DOI
  61. Pimentel, 2017, Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity, Dig Dis Sci, 62, 10.1007/s10620-017-4598-7 · DOI
  62. Fodor, 2019, Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome, Gut Microbes, 10, 22, 10.1080/19490976.2018.1460013 · DOI
  63. Low, 2010, A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test, J Clin Gastroenterol, 44, 10.1097/MCG.0b013e3181c64c90 · DOI · Paper page
  64. Pimentel, 2006, Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study, Dig Dis Sci, 51, 10.1007/s10620-006-9104-6 · DOI · Paper page
  65. Rezaie, 2019, Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea, Am J Gastroenterol, 114, 10.14309/ajg.0000000000000444 · DOI
  66. Gupta, 2016, Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients, Am J Gastroenterol, 111, 10.1038/ajg.2016.32 · DOI
  67. Luscombe, 2000, Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review, Qual Life Res, 9, 10.1023/A:1008970312068 · DOI
  68. Gaynes, 1999, The role of psychosocial factors in irritable bowel syndrome, Baillieres Best Pract Res Clin Gastroenterol, 13, 10.1053/bega.1999.0038 · DOI
  69. Rao, 2018, Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis, Clin Transl Gastroenterol, 9, 162, 10.1038/s41424-018-0030-7 · DOI
  70. Thompson, 2012, Current management of short bowel syndrome, Curr Probl Surg, 49, 52, 10.1067/j.cpsurg.2011.10.002 · DOI
  71. Jackson, 2015, Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study, Sleep Sci, 8, 10.1016/j.slsci.2015.10.001 · DOI
  72. Leite, 2019, Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study, BMC Microbiol, 19, 239, 10.1186/s12866-019-1617-1 · DOI
  73. Saffouri, 2019, Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders, Nat Commun, 10, 2012, 10.1038/s41467-019-09964-7 · DOI
  74. Linden, 2014, Hydrogen sulfide signaling in the gastrointestinal tract, Antioxid Redox Signal, 20, 10.1089/ars.2013.5312 · DOI
  75. Singer-Englar, 2018, 182 - Competitive Hydrogen Gas Utilization by Methane- and Hydrogen Sulfide-Producing Microorganisms and Associated Symptoms: Results of a Novel 4-Gas Breath Test Machine, Gastroenterology, 154, S, 10.1016/S0016-5085(18)30625-5 · DOI

Cited by

Metadata

Authors
Takakura, W., & Pimentel, M.
Venue
Frontiers in Psychiatry
Publisher
Frontiers Media SA
Published
2020-07-10
Volume
11
ISSN
1664-0640
DOI
10.3389/fpsyt.2020.00664
Cited by
148
References
23
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.